Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Global Regulatory News (JARA)

Share Price Information for Jpmorgan Global (JARA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 72.80
Bid: 71.40
Ask: 72.80
Change: 0.80 (1.11%)
Spread: 1.40 (1.961%)
Open: 71.40
High: 72.80
Low: 71.40
Prev. Close: 72.00
JARA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New Research

29 Jan 2024 07:00

RNS Number : 0745B
JPMorgan Global Core Real Assets Ld
29 January 2024
 

JPMorgan Global Core Real Assets: New Research

29/01/2024

Prospective returns on the real assets sectors JARA invests in have been written up?

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEANFKASSLEEA
Date   Source Headline
12th Apr 20245:10 pmRNSQuotedData's Weekly News & Interview
8th Apr 20247:00 amRNSMonthly Portfolio Update
3rd Apr 20246:25 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:04 pmRNSBlock listing Interim Review
2nd Apr 20245:00 pmRNSClosed Period Announcement
25th Mar 20244:33 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSQuarterly Net Asset Value and Portfolio Update
15th Mar 20245:46 pmRNSDirector/PDMR Shareholding
1st Mar 20249:53 amRNSTotal Voting Rights
19th Feb 20244:54 pmRNSTransaction in Own Shares
16th Feb 20244:53 pmRNSTransaction in Own Shares
15th Feb 20245:09 pmRNSTransaction in Own Shares
13th Feb 20245:09 pmRNSTransaction in Own Shares
7th Feb 20245:00 pmRNSTransaction in Own Shares
7th Feb 20247:00 amRNSMonthly Portfolio Update
6th Feb 20244:51 pmRNSTransaction in Own Shares
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20244:57 pmRNSTransaction in Own Shares
2nd Feb 20244:47 pmRNSTransaction in Own Shares
29th Jan 20247:00 amRNSKepler Trust Intelligence: New Research
18th Jan 20247:00 amRNSDividend Declaration
5th Jan 20247:00 amRNSMONTHLY PORTFOLIO UPDATE
2nd Jan 202411:39 amRNSTotal Voting Rights
21st Dec 20237:00 amRNSNet Asset Value(s)
19th Dec 20234:23 pmRNSTransaction in Own Shares
1st Dec 202312:17 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSHalf-year Report
21st Nov 20237:00 amRNSLive Webinar hosted by Capital Access Group
10th Nov 20237:00 amRNSMonthly Net Asset Value
8th Nov 20235:00 pmRNSTransaction in Own Shares
7th Nov 20235:01 pmRNSTransaction in Own Shares
3rd Nov 20235:11 pmRNSTransaction in Own Shares
2nd Nov 20235:18 pmRNSTransaction in Own Shares
1st Nov 20235:20 pmRNSTransaction in Own Shares
1st Nov 202311:13 amRNSTotal Voting Rights
31st Oct 20235:07 pmRNSTransaction in Own Shares
30th Oct 20234:13 pmRNSTransaction in Own Shares
27th Oct 20235:12 pmRNSTransaction in Own Shares
26th Oct 20235:14 pmRNSTransaction in Own Shares
24th Oct 20235:18 pmRNSTransaction in Own Shares
18th Oct 20237:00 amRNSDividend Declaration
13th Oct 20234:48 pmRNSTransaction in Own Shares
12th Oct 20235:07 pmRNSTransaction in Own Shares
10th Oct 20235:01 pmRNSTransaction in Own Shares
9th Oct 20235:03 pmRNSTransaction in Own Shares
6th Oct 20235:16 pmRNSTransaction in Own Shares
4th Oct 20237:00 amRNSMonthly Net Asset Value
3rd Oct 20235:19 pmRNSTransaction in Own Shares
2nd Oct 202311:35 amRNSTotal Voting Rights
28th Sep 20234:58 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.